Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

NurPhoto/Getty Images VC funding for European biotech startups is on track for a record year, though the gap with the US ...

VERAXA Biotech (NASDAQ: VRXA) announced a collaboration with AI-driven bioinformatics company Ardigen S.A. to support ...

Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Michael Yee, UBS biotech analyst, joins 'The Exchange' to discuss Yee's thoughts on biotech stocks, what's driving the ...

It's been a volatile year for the company, but don't let that scare you away.

CNBC’s Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter. Instead, he highlighted a group ...

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

Biotechnology companies are coming out of a dark period for the industry. Why has the tide turned and is now a good time to ...

Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking in 2026 is off to a strong start.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.